Quantitative imaging for evaluation of response to cancer therapy
- PMID: 19956378
- PMCID: PMC2781068
- DOI: 10.1593/tlo.09217
Quantitative imaging for evaluation of response to cancer therapy
References
-
- Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng E, Cheson BD, O'Shaughnessy J, Guyton KZ, Mankoff DA, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res. 2005;11:2785–2808. - PubMed
-
- Kelloff GJ, Sullivan DC, Wilson W, Cheson B, Juweid M, Mills GQ, Zelenetz AD, Horning SJ, Weber W, Sargent DJ, et al. FDG-PET Lymphoma Demonstration Project Invitational Workshop. Acad Radiol. 2007;14:330–339. - PubMed
-
- Kelloff GJ, Krohn KA, Larson SM, Weissleder R, Mankoff DA, Hoffman JM, Link JM, Guyton KZ, Eckelman WC, Scher HI, et al. The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res. 2005;11:7967–7985. - PubMed
-
- Weber WA. Positron emission tomography as an imaging biomarker. J Clin Oncol. 2006;24:3282–3292. - PubMed
LinkOut - more resources
Full Text Sources